Royal Bank of Canada’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-35
Closed 6577
2024
Q4
$0 Buy
+35
New ﹤0.01% 6537
2024
Q3
Sell
-149
Closed -$1K 6704
2024
Q2
$1K Sell
149
-60
-29% -$403 ﹤0.01% 6463
2024
Q1
$3K Buy
209
+65
+45% +$933 ﹤0.01% 6151
2023
Q4
$2K Sell
144
-6
-4% -$83 ﹤0.01% 6277
2023
Q3
$1K Buy
150
+7
+5% +$47 ﹤0.01% 6412
2023
Q2
$3K Sell
143
-9
-6% -$189 ﹤0.01% 6333
2023
Q1
$3K Buy
152
+3
+2% +$59 ﹤0.01% 6308
2022
Q4
$4K Sell
149
-7
-4% -$188 ﹤0.01% 6322
2022
Q3
$5K Buy
156
+5
+3% +$160 ﹤0.01% 6244
2022
Q2
$6K Sell
151
-112
-43% -$4.45K ﹤0.01% 6118
2022
Q1
$11K Buy
263
+120
+84% +$5.02K ﹤0.01% 6419
2021
Q4
$7K Sell
143
-126
-47% -$6.17K ﹤0.01% 6613
2021
Q3
$17K Buy
269
+126
+88% +$7.96K ﹤0.01% 6246
2021
Q2
$6K Sell
143
-15,500
-99% -$650K ﹤0.01% 6520
2021
Q1
$821K Sell
15,643
-589
-4% -$30.9K ﹤0.01% 3336
2020
Q4
$1.1M Buy
16,232
+359
+2% +$24.4K ﹤0.01% 2954
2020
Q3
$608K Hold
15,873
﹤0.01% 3263
2020
Q2
$614K Buy
15,873
+52
+0.3% +$2.01K ﹤0.01% 3191
2020
Q1
$474K Buy
15,821
+118
+0.8% +$3.54K ﹤0.01% 3233
2019
Q4
$1.78M Buy
15,703
+60
+0.4% +$6.81K ﹤0.01% 2490
2019
Q3
$494K Sell
15,643
-38
-0.2% -$1.2K ﹤0.01% 3323
2019
Q2
$672K Hold
15,681
﹤0.01% 3135
2019
Q1
$855K Hold
15,681
﹤0.01% 2827
2018
Q4
$466K Hold
15,681
﹤0.01% 3187
2018
Q3
$722K Hold
15,681
﹤0.01% 3089
2018
Q2
$340K Sell
15,681
-2
-0% -$43 ﹤0.01% 3525
2018
Q1
$599K Buy
15,683
+8,995
+134% +$344K ﹤0.01% 3022
2017
Q4
$387K Sell
6,688
-83
-1% -$4.8K ﹤0.01% 3288
2017
Q3
$447K Sell
6,771
-2,405
-26% -$159K ﹤0.01% 3249
2017
Q2
$775K Buy
9,176
+2,495
+37% +$211K ﹤0.01% 2715
2017
Q1
$925K Buy
+6,681
New +$925K ﹤0.01% 2620